European acquisition leads to record revenue for Canadian cannabis LP Organigram Global

Organigram Global's record revenue of CA$105.8 million in Q3, a 49% increase, is a significant milestone for the Canadian cannabis LP. This growth is largely attributed to its acquisition of Sanity Group, a European cannabis company, which has successfully expanded Organigram's international presence. The acquisition has led to international sales accounting for 35% of the company's total revenue.

This development is noteworthy in the hemp and cannabis industry as it highlights the strategic importance of global expansion for Canadian LP companies. With the Canadian market facing increasing competition and pricing pressures, companies like Organigram are looking to international markets, particularly Europe, to drive growth. The European cannabis market is expected to continue its rapid expansion, driven by increasing demand and regulatory changes.

To watch next: Organigram's ability to integrate Sanity Group and capitalize on European market opportunities will be crucial to sustaining its growth momentum. Additionally, investors will be monitoring the company's progress in navigating complex regulatory environments and executing on its plans to expand its product offerings and distribution networks in Europe. The hemp and cannabis industry will also be keeping an eye on how other Canadian LP companies respond to Organigram's European expansion strategy.

Originally reported by mjbizdaily.com. HempNews adds analysis for cannabis & hemp readers.